Cronos: Geographic Expansion Backed By A Strong Balance Sheet

Disruptive Investor5.47K FollowersFollow5ShareSavePlay(10min)CommentsSummaryCronos remains a Strong Buy, supported by robust fundamentals, international expansion, and a depressed $1B valuation with $784M in cash.CRON’s acquisition of CanAdelaar and expansion into Europe and Australia position it for accelerated growth and margin improvement over the next 24-36 months.GrowCo’s completed capacity expansion and 70% flower volume increase in 2026 are expected to drive top-line and EBITDA margin gains.Regulatory catalysts, including potential US cannabis reclassification and liberalization in Europe, could unlock further upside for CRON’s growth strategy. Morsa Images/DigitalVision via Getty Images Update Coverage on Cronos I last talked about Cronos (CRON) in March 2025 and I opined that the stock is a “Strong Buy.” Since that discussion, Cronos stock has trended higher by 38%. AsThis article was written byDisruptive Investor5.47K FollowersFollowAnalyst with interest in various asset classes for portfolio diversification. My field of expertise includes equities, precious metals, commodities and cryptocurrencies. Special interest and love for economics.Analyst’s Disclosure: I/we have a beneficial long position in the shares of CRON either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.